Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors.
暂无分享,去创建一个
Luigi Naldini | Napoleone Ferrara | Michele De Palma | L. Naldini | C. Lewis | N. Ferrara | Michele De Palma | S. Coffelt | M. D. Palma | Seth B Coffelt | Claire E Lewis | J Martin Brown | J. Brown | J. Brown | Michele De | Palma | Claire E. Lewis | J. Martin Brown
[1] S. Gordon,et al. The use and limitation of monoclonal antibodies against mononuclear phagocytes. , 1982, Immunobiology.
[2] C. Lewis,et al. Expression of Tie-2 by Human Monocytes and Their Responses to Angiopoietin-21 , 2007, The Journal of Immunology.
[3] H. Friess,et al. VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma , 2008, British Journal of Cancer.
[4] D. Hicklin,et al. Therapy-Induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors , 2006, Science.
[5] D. Hicklin,et al. Expression and localization of vascular endothelial growth factor receptors in human hepatocellular carcinoma and non-HCC tissues. , 2000, Oncology reports.
[6] Michael D. Connolly,et al. Use of Ly6G‐specific monoclonal antibody to deplete neutrophils in mice , 2008, Journal of leukocyte biology.
[7] D. Hanahan,et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. , 1999, Genes & development.
[8] S. Rafii,et al. Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth , 2001, Nature Medicine.
[9] B. Fingleton,et al. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. , 2004, Cancer cell.
[10] Na Zhang,et al. Deletion of Vascular Endothelial Growth Factor in myeloid cells accelerates tumorigenesis , 2008, Nature.
[11] K. Shitara,et al. and surface marker for the lineage of monocyte-macrophages in humans Flt-1 , vascular endothelial growth factor receptor 1 , is a novel cell , 2001 .
[12] G. Evan,et al. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors , 2007, Nature Medicine.
[13] Howard Y. Chang,et al. Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment. , 2009, Cancer cell.
[14] A. Harris,et al. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. , 1996, Cancer research.
[15] S. Rafii,et al. Magnitude of Stromal Hemangiogenesis Correlates with Histologic Subtype of Non–Hodgkin's Lymphoma , 2006, Clinical Cancer Research.
[16] R. Weissleder,et al. Mast cells are an essential hematopoietic component for polyp development , 2007, Proceedings of the National Academy of Sciences.
[17] R. Galli,et al. Tie2 identifies a hematopoietic monocytes required for tumor lineage of proangiogenic vessel formation and a mesenchymal population of pericyte progenitors , 2005 .
[18] D. Hanahan,et al. MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis , 2000, Cell.
[19] J. Pollard,et al. A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors , 2004, Cancer Research.
[20] L. Naldini,et al. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells , 2003, Nature Medicine.
[21] A. Harris,et al. Expression of vascular endothelial growth factor by macrophages is up‐regulated in poorly vascularized areas of breast carcinomas , 2000, The Journal of pathology.
[22] Masahiro Inoue,et al. An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. , 2004, The Journal of clinical investigation.
[23] J. Nyhus,et al. Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. , 2002, Cancer research.
[24] Luigi Naldini,et al. Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. , 2007, Blood.
[25] L. Naldini,et al. Role of haematopoietic cells and endothelial progenitors in tumour angiogenesis. , 2006, Biochimica et biophysica acta.
[26] G. Coukos,et al. Role of vascular leukocytes in ovarian cancer neovascularization. , 2008, Advances in experimental medicine and biology.
[27] J. Favier,et al. Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. , 2005, Blood.
[28] N. Altorki,et al. Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression. , 2009, Biochimica et biophysica acta.
[29] A. Griffioen,et al. Angiogenic Profile of Breast Carcinoma Determines Leukocyte Infiltration , 2004, Clinical Cancer Research.
[30] L. Yao,et al. Mast cell-derived angiopoietin-1 plays a critical role in the growth of plasma cell tumors. , 2004, The Journal of clinical investigation.
[31] P. Allavena,et al. Cancer-related inflammation , 2008, Nature.
[32] Michelle Collazo,et al. Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice1 , 2008, The Journal of Immunology.
[33] M. Yoder,et al. Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system , 2009, Current opinion in hematology.
[34] Andrea Falini,et al. Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis. , 2008, Cancer cell.
[35] Josefina Garcia. Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A , 2004 .
[36] G. Fuh,et al. Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells , 2007, Nature Biotechnology.
[37] S. Vandenberg,et al. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. , 2008, Cancer cell.
[38] 梅村 直己,et al. Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics , 2008 .
[39] G. Cheng,et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. , 2009, Cancer cell.
[40] Ruth J. Muschel,et al. A Distinct Macrophage Population Mediates Metastatic Breast Cancer Cell Extravasation, Establishment and Growth , 2009, PloS one.
[41] G. Ahn,et al. Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. , 2008, Cancer cell.
[42] Christopher Chiu,et al. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis , 2006, Proceedings of the National Academy of Sciences.
[43] F. Marincola,et al. Migration deficit in monocyte-macrophages in human ovarian cancer , 2008, Cancer Immunology, Immunotherapy.
[44] E. Crivellato,et al. Mast cells and tumour angiogenesis: new insight from experimental carcinogenesis. , 2008, Cancer letters.
[45] A. Griffioen,et al. Proliferating endothelial cells and leukocyte infiltration as prognostic markers in colorectal cancer. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[46] Steffen Jung,et al. Blood monocytes consist of two principal subsets with distinct migratory properties. , 2003, Immunity.
[47] Christian J Wiedermann,et al. Expression and function of the angiopoietin receptor Tie-2 in human eosinophils. , 2004, The Journal of allergy and clinical immunology.
[48] A. Horrevoets. Angiogenic monocytes: another colorful blow to endothelial progenitors. , 2009, The American journal of pathology.
[49] Robert S. Kerbel,et al. The multifaceted circulating endothelial cell in cancer: towards marker and target identification , 2006, Nature Reviews Cancer.
[50] John Condeelis,et al. Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis , 2006, Cell.
[51] T. Suda,et al. Hematopoietic cells regulate the angiogenic switch during tumorigenesis. , 2005, Blood.
[52] M. Azuma,et al. The existence of CD11c+ sentinel and F4/80+ interstitial dendritic cells in dental pulp and their dynamics and functional properties. , 2006, International immunology.
[53] P. Sinha,et al. Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer 1 , 2009, The Journal of Immunology.
[54] J. Starkey,et al. Mast‐cell‐deficient W/Wv mice exhibit A decreased rate of tumor angiogenesis , 1988, International journal of cancer.
[55] G. Coukos,et al. Vascular leukocytes contribute to tumor vascularization. , 2005, Blood.
[56] R. Welsh,et al. CD11b (Mac-1): a marker for CD8+ cytotoxic T cell activation and memory in virus infection. , 1992, Journal of immunology.
[57] M. Giacca,et al. Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels , 2007, Cell.
[58] Luigi Naldini,et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. , 2005, Cancer cell.
[59] A. Cumano,et al. Monitoring of Blood Vessels and Tissues by a Population of Monocytes with Patrolling Behavior , 2007, Science.
[60] Craig Murdoch,et al. The role of myeloid cells in the promotion of tumour angiogenesis , 2008, Nature Reviews Cancer.
[61] W. Gerald,et al. Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. , 2003, Cancer cell.
[62] G. Coukos,et al. Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer , 2009, Journal of Translational Medicine.
[63] A. Sica,et al. Altered macrophage differentiation and immune dysfunction in tumor development. , 2007, The Journal of clinical investigation.
[64] J. Pollard,et al. Tumor-associated macrophages press the angiogenic switch in breast cancer. , 2007, Cancer research.
[65] S. Gordon,et al. Myeloid‐specific gene expression , 1998, Journal of leukocyte biology.
[66] A. Sica,et al. A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships. , 2009, Blood.
[67] I. Weissman,et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth , 2008, Proceedings of the National Academy of Sciences.
[68] S. Gordon,et al. Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.
[69] F. Peale,et al. Bv8 regulates myeloid-cell-dependent tumour angiogenesis , 2007, Nature.
[70] C. Liu,et al. Targeting tumor-associated macrophages as a novel strategy against breast cancer. , 2006, The Journal of clinical investigation.
[71] M. Mcgarry,et al. Murine Eosinophil Granulocytes Bind the Murine Macrophage‐Monocyte Specific Monoclonal Antibody F4/80 , 1991, Journal of leukocyte biology.
[72] Fabian Kiessling,et al. Flt-1 signaling in macrophages promotes glioma growth in vivo. , 2008, Cancer research.
[73] S. Rafii,et al. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. , 2007, Trends in immunology.
[74] M. Reed,et al. Macrophages promote angiogenesis in human breast tumour spheroids in vivo , 2005, British Journal of Cancer.
[75] J. Pollard,et al. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. , 2006, Cancer research.
[76] K. Hirschi,et al. Assessing identity, phenotype, and fate of endothelial progenitor cells. , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[77] D. Scheinberg,et al. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. , 2007, Genes & development.
[78] P. De Baetselier,et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. , 2008, Blood.
[79] J. Pollard,et al. Distinct role of macrophages in different tumor microenvironments. , 2006, Cancer research.
[80] K. Alitalo,et al. Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. , 2004, Blood.
[81] D. Nolan,et al. Endothelial Progenitor Cells Control the Angiogenic Switch in Mouse Lung Metastasis , 2008, Science.
[82] R. Jain. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.
[83] Baocun Sun,et al. Correlation between melanoma angiogenesis and the mesenchymal stem cells and endothelial progenitor cells derived from bone marrow. , 2005, Stem cells and development.
[84] Mark A. Hall,et al. Hemostasis, Thrombosis, and Vascular Biology Materials and Methods Lacz and Platelet Endothelial Cell Adhesion Molecule 1 (pecam-1) Staining , 2022 .
[85] I. Fidler,et al. Circulating monocytes expressing CD31: implications for acute and chronic angiogenesis. , 2009, The American journal of pathology.
[86] L. Naldini,et al. Tie2-expressing monocytes (TEMs): novel targets and vehicles of anticancer therapy? , 2009, Biochimica et biophysica acta.
[87] S. Gordon,et al. EMR1, the human homolog of F4/80, is an eosinophil‐specific receptor , 2007, European journal of immunology.
[88] Gavin Thurston,et al. Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system , 2009, Nature Reviews Molecular Cell Biology.
[89] S. Gordon,et al. Molecular Cloning of F4/80, a Murine Macrophage-restricted Cell Surface Glycoprotein with Homology to the G-protein-linked Transmembrane 7 Hormone Receptor Family (*) , 1996, The Journal of Biological Chemistry.
[90] A. Mantovani,et al. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. , 1996, Blood.
[91] Shigeyoshi Itohara,et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.
[92] Mikala Egeblad,et al. Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopy , 2008, Disease Models & Mechanisms.
[93] L. Naldini,et al. Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications. , 2007, Trends in immunology.
[94] Craig Murdoch,et al. Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response. , 2008, Neoplasia.
[95] P. Allavena,et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.
[96] Andrew V. Nguyen,et al. Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.
[97] Meng Yang,et al. Color-coded fluorescence imaging of tumor-host interactions , 2006, Nature Protocols.
[98] B. Passlick,et al. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. , 1989, Blood.
[99] J. Talmadge,et al. Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. , 2008, Blood.
[100] Z. Werb,et al. PDGFRβ+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival , 2005, Nature Cell Biology.
[101] Mallika Singh,et al. Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression , 2008, Proceedings of the National Academy of Sciences.
[102] N. Ferrara,et al. Role of myeloid cells in tumor angiogenesis and growth. , 2008, Trends in cell biology.
[103] S. Dudas,et al. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[104] Srinivas Nagaraj,et al. Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.
[105] L. Coussens,et al. Immune Cells and Inflammatory Mediators as Regulators of Tumor Angiogenesis , 2008 .